REHEALTH Trademark

Trademark Overview


On Thursday, November 29, 2012, a trademark application was filed for REHEALTH with the United States Patent and Trademark Office. The USPTO has given the REHEALTH trademark a serial number of 85790134. The federal status of this trademark filing is ABANDONED - EXPRESS as of Thursday, October 17, 2013. This trademark is owned by Davinci Biosciences LLC. The REHEALTH trademark is filed in the Pharmaceutical Products category with the following description:

Immune cells, namely, cells for medical or veterinary use; tissue cells, namely, cells for medical or veterinary use; biological tissues, namely, stem cells, progenitor cells, immune cells, tumor cells, blood-derived cells, stromal cells, connective tissue, support tissue, organ tissue, adipose and soft tissue, vascular tissue, skin and surface tissues, mucosal tissue, neural tissue, decellularized tissue, demineralized tissue, umbilical cords, placentas, bone marrow and tumor tissue for medical or veterinary use; Prophylactic and therapeutic vaccines; immune cells for medical use; pharmaceutical preparations for stimulating the immune system; pharmaceutical preparations for the treatment of immune system related diseases and conditions; Biochemicals, namely, proteases for use in human therapeutics, namely, for the treatment of infectious, auto-immune, cell-proliferative, inflammatory, metabolic, cardiovascular, respiratory, neurological, and musculoskeletal disorders and diseases
rehealth

General Information


Serial Number85790134
Word MarkREHEALTH
Filing DateThursday, November 29, 2012
Status601 - ABANDONED - EXPRESS
Status DateThursday, October 17, 2013
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements


Goods and ServicesImmune cells, namely, cells for medical or veterinary use; tissue cells, namely, cells for medical or veterinary use; biological tissues, namely, stem cells, progenitor cells, immune cells, tumor cells, blood-derived cells, stromal cells, connective tissue, support tissue, organ tissue, adipose and soft tissue, vascular tissue, skin and surface tissues, mucosal tissue, neural tissue, decellularized tissue, demineralized tissue, umbilical cords, placentas, bone marrow and tumor tissue for medical or veterinary use; Prophylactic and therapeutic vaccines; immune cells for medical use; pharmaceutical preparations for stimulating the immune system; pharmaceutical preparations for the treatment of immune system related diseases and conditions; Biochemicals, namely, proteases for use in human therapeutics, namely, for the treatment of infectious, auto-immune, cell-proliferative, inflammatory, metabolic, cardiovascular, respiratory, neurological, and musculoskeletal disorders and diseases
Pseudo MarkRE HEALTH

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateFriday, December 7, 2012
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameDavinci Biosciences LLC
Party Type10 - Original Applicant
Legal Entity Type16 - Limited Liability Company
AddressCosta Mesa, CA 62627

Trademark Events


Event DateEvent Description
Thursday, October 17, 2013ABANDONMENT NOTICE MAILED - EXPRESS ABANDONMENT
Thursday, October 17, 2013ABANDONMENT - EXPRESS MAILED
Wednesday, October 16, 2013TEAS EXPRESS ABANDONMENT RECEIVED
Wednesday, October 16, 2013EXAMINER'S AMENDMENT ENTERED
Wednesday, October 16, 2013NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Wednesday, October 16, 2013EXAMINERS AMENDMENT E-MAILED
Wednesday, October 16, 2013EXAMINERS AMENDMENT -WRITTEN
Wednesday, March 20, 2013NOTIFICATION OF PRIORITY ACTION E-MAILED
Wednesday, March 20, 2013PRIORITY ACTION E-MAILED
Wednesday, March 20, 2013PRIORITY ACTION WRITTEN
Wednesday, March 20, 2013ASSIGNED TO EXAMINER
Saturday, December 8, 2012NOTICE OF PSEUDO MARK MAILED
Friday, December 7, 2012NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Monday, December 3, 2012NEW APPLICATION ENTERED IN TRAM